Myriad Genetics, Inc. - Common Stock (NQ:MYGN)
Price and Volume
Detailed Quote| Volume | 2,263,623 |
| Open | 4.160 |
| Bid (Size) | 4.440 (100) |
| Ask (Size) | 4.520 (900) |
| Prev. Close | 4.060 |
| Today's Range | 4.160 - 4.585 |
| 52wk Range | 2.740 - 8.590 |
| Shares Outstanding | 93,500,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
47.1% below 52-week high
4.540
2.7452W Low
8.5952W High
1 Week
4.051W Low
4.381W High
Myriad Genetics, Inc. - Common Stock (MYGN) traded between $2.74 and $8.59 over the past 52 weeks and last traded at $4.54, 47.1% below its 52-week high. Over the past week it ranged between $4.05 and $4.38.
Past 12 Months
1W
+$0.37
1M
+$1.36
3M
-$1.45
6M
-$0.21
YTD
-$1.60
1Y
-$3.19
MYGN was -41.3% over the past year, -4.4% over six months, -26.1% year to date, +8.9% in the last week.
12 Months vs Market
MYGN
-41.3%
DIA
+10.1%
SPY
+15.1%
QQQ
+24.3%
IWM
+16.1%
Over the past 12 months MYGN returned -41.3% versus DIA (Dow) +10.1%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.1%.
Volume & Liquidity
1.15× 3-mo avg
Today 2,263,623
3-mo avg 2.0M
1W
1.5M
1M
2.1M
3M
2.0M
6M
1.8M
YTD
1.8M
1Y
1.6M
MYGN most recently traded 2,263,623 shares against a 3-month average daily volume of 2.0M.
More News
Read More
3 Reasons MYGN is Risky and 1 Stock to Buy Instead
September 24, 2026
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
September 17, 2026
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
2 Unprofitable Stocks to Research Further and 1 We Find Risky
September 15, 2026
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Why Myriad Genetics (MYGN) Stock Is Down Today
September 01, 2026
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
August 18, 2026
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
August 17, 2026
3 Healthcare Stocks with Open Questions
August 10, 2026
Myriad Genetics Q2 Earnings Call Highlights ↗
July 31, 2026
Top movers in Friday's session ↗
July 31, 2026
Why Myriad Genetics (MYGN) Shares Are Falling Today
July 31, 2026
Top stock movements in today's session. ↗
July 31, 2026
Frequently Asked Questions
Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.540
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 424.49M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 424M shares outstanding.